Home  /  Resource Library  /  Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403

Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403

Results of a study examining bortezomib following autologous stem cell transplant for treatment of mantle cell lymphoma.